Literature DB >> 6894823

Histomorphometric evaluation of the effects of intermittent 1,25-dihydroxycholecalciferol administration on cortical bone remodeling in adult dogs.

W B High, C C Capen, H E Black.   

Abstract

The effects of intermittent low doses (1.25 mug daily, administered intravenously for 6 days and withdrawn for 14 days for 3 complete cycles) of 1,25-dihydroxycholecalciferol (1,25-[OH](2)D(3)) on cortical bone were determined and compared in ribs with steady state and regionally accelerated remodeling in adult intact female dogs. The bone changes were analyzed by dynamic bone histomorphometric methods, using tetracycline and DCAF (2,4 BIS) N, N' di (carboxymethyl) (amino methyl fluorescein) in vivo double labeling of bones before treatment and after 60 days of intermittent 1,25-(OH)(2)D(3) administration. Serum calcium and phosphorus levels increased during 1,25-(OH)(2)D(3) administration. Urinary hydroxyproline excretion increased during the first interval of 1,25-(OH)(2)D(3) administration but was not changed significantly during the last two intervals. In normal cortical bone (11th rib) following the administration of 1,25-(OH)(2)D(3) there was a marked decrease in the activation frequency, bone formation rate, osteoid seam thickness, seam circumference, and mean appositional rate. Although recruitment of new remodeling sites was decreased after 1,25-(OH)(2)D(3), previously existing remodeling units continued to completion. These effects resulted in a preponderance of mature osteons in normal cortical bone. The morphometric changes in cortical bone (9th rib) exposed to both 1,25-(OH)(2)D(3) and periosteal elevation were characterized by a marked increase in both the activation frequency and bone formation rate and associated with a decrease in the osteon formation time. Other morphometric parameters that were increased included radial closure rate, numbers of osteoid seams and resorption cavities, ratio of bone resorbing to forming sites, percentage labeled and circumference of osteoid seams, and total and cortical bone areas. The combined effect of periosteal elevation and 1,25-(OH)(2)D(3) were markedly different from those observed with 1,25-(OH)(2)D(3) alone. These findings suggest that the rapid bone turnover induced by tissue injury will mask or alter the effects of hormones on bone remodeling when studied over a relatively short period of time.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894823      PMCID: PMC1903742     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Stimulation of bone growth by periosteal stripping. A clinical study.

Authors:  D H Jenkins; D H Cheng; A R Hodgson
Journal:  J Bone Joint Surg Br       Date:  1975-11

2.  Modifications of a specific assay for hydroxyproline in urine.

Authors:  K I Kivirikko; O Laitinen; D J Prockop
Journal:  Anal Biochem       Date:  1967-05       Impact factor: 3.365

Review 3.  Hormonal control of skeletal and mineral homeostasis.

Authors:  H Rasmussen; P Bordier; K Kurokawa; N Nagata; E Ogata
Journal:  Am J Med       Date:  1974-06       Impact factor: 4.965

4.  Two-color fluorescent labeling of mineralizing tissues with tetracycline and 2,4-bis[N,N'-di-(carbomethyl)aminomethyl] fluorescein.

Authors:  H K Suzuki; A Mathews
Journal:  Stain Technol       Date:  1966-01

5.  A bone stain for osteoid seams in fresh, unembedded, mineralized bone.

Authors:  A R Villanueva
Journal:  Stain Technol       Date:  1974-01

Review 6.  Tetracycline-based histological analysis of bone remodeling.

Authors:  H M Frost
Journal:  Calcif Tissue Res       Date:  1969

7.  The effect of low calcium intake and vitamin D supplements on bone structure in young growing dogs.

Authors:  J R Campbell; T A Douglas
Journal:  Br J Nutr       Date:  1965       Impact factor: 3.718

8.  Decrease in serum immunoreactive parathyroid hormone in rats and in parathyroid hormone secretion in vitro by 1,25-dihydroxycholecalciferol.

Authors:  B S Chertow; D J Baylink; J E Wergedal; M H Su; A W Norman
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

9.  1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture.

Authors:  L G Raisz; C L Trummel; M F Holick; H F DeLuca
Journal:  Science       Date:  1972-02-18       Impact factor: 47.728

10.  The localization of 1,25-dihydroxycholecalciferol in bone cell nuclei of rachitic chicks.

Authors:  J C Weber; V Pons; E Kodicek
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

View more
  4 in total

Review 1.  Use of calciferol and its metabolites and analogues in osteoporosis. Current status.

Authors:  A M Parfitt
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

2.  The effects of 17 beta-estradiol and progestagen on trabecular bone remodeling in oophorectomized dogs.

Authors:  G R Snow; C Anderson
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

3.  Oophorectomy and cortical bone remodeling in the beagle.

Authors:  G R Snow; M A Cook; C Anderson
Journal:  Calcif Tissue Int       Date:  1984-09       Impact factor: 4.333

4.  1,25(OH)2D3 alters growth plate maturation and bone architecture in young rats with normal renal function.

Authors:  Anna Idelevich; Michael Kerschnitzki; Ron Shahar; Efrat Monsonego-Ornan
Journal:  PLoS One       Date:  2011-06-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.